Xiao et al. demonstrated a potential tumor-suppressive role of eukaryotic elongation factor-2 kinase (eEF2K) in lung cancer cells through phosphorylation of PKM2 at Thr129 and the subsequent alteration in its nuclear translocation and STAT3 activation [136]. Here, EEF2K is linked to lung carcinoma.